These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1530547)

  • 1. Taming demons: the reduction of harm resulting from use of illicit drugs.
    Wodak A
    Aust N Z J Med; 1992 Apr; 22(2):204-8. PubMed ID: 1530547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug prohibition and the treatment system: perfect together.
    Magura S
    Subst Use Misuse; 2007; 42(2-3):495-501. PubMed ID: 17558947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.
    Ritter A; Cameron J
    Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dutch drug policy: a model for America?
    Duncan DF; Nicholson T
    J Health Soc Policy; 1997; 8(3):1-15. PubMed ID: 10172982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How well do international drug conventions protect public health?
    Room R; Reuter P
    Lancet; 2012 Jan; 379(9810):84-91. PubMed ID: 22225673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of drug policy liberalisation on willingness to seek help for problem drug use: A comparison of 20 countries.
    Benfer I; Zahnow R; Barratt MJ; Maier L; Winstock A; Ferris J
    Int J Drug Policy; 2018 Jun; 56():162-175. PubMed ID: 29731288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The size and mix of government spending on illicit drug policy in Australia.
    Moore TJ
    Drug Alcohol Rev; 2008 Jul; 27(4):404-13. PubMed ID: 18584391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harm reduction and decriminalization in the United States: a personal perspective.
    DuPont RL
    Subst Use Misuse; 1996 Dec; 31(14):1929-45; discussion 1947-72. PubMed ID: 8969018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harm reduction: Australia as a case study.
    Wodak A
    Bull N Y Acad Med; 1995; 72(2):339-47. PubMed ID: 10101374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Policy and the Public Good: a summary of the book.
    Drugs and Public Policy Group
    Addiction; 2010 Jul; 105(7):1137-45. PubMed ID: 20642498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supply control policy, harm reduction and context dependence.
    Weatherburn D
    Addiction; 2005 Jul; 100(7):927-8; discussion 930-2. PubMed ID: 15955006
    [No Abstract]   [Full Text] [Related]  

  • 12. The analysis of policy: understanding the process of policy development.
    Ryder D
    Addiction; 1996 Sep; 91(9):1265-70. PubMed ID: 8854357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlling and policing substance use(rs).
    White T
    Subst Use Misuse; 2002; 37(8-10):973-83. PubMed ID: 12180573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supply reduction's hidden casualties: a view from the trenches.
    Strathdee SA; Patterson TL
    Addiction; 2009 Mar; 104(3):340-1; discussion 345-6. PubMed ID: 19207337
    [No Abstract]   [Full Text] [Related]  

  • 15. Today's fentanyl crisis: Prohibition's Iron Law, revisited.
    Beletsky L; Davis CS
    Int J Drug Policy; 2017 Aug; 46():156-159. PubMed ID: 28735773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol of the impact of alternative social assistance disbursement on drug-related harm (TASA) study: a randomized controlled trial to evaluate changes to payment timing and frequency among people who use illicit drugs.
    Richardson L; Laing A; Milloy MJ; Maynard R; Nosyk B; Marshall B; Grafstein E; Daly P; Wood E; Montaner J; Kerr T
    BMC Public Health; 2016 Jul; 16():668. PubMed ID: 27473400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug policy and the public good: evidence for effective interventions.
    Strang J; Babor T; Caulkins J; Fischer B; Foxcroft D; Humphreys K
    Lancet; 2012 Jan; 379(9810):71-83. PubMed ID: 22225672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical and legal issues in the control of drug abuse and drug trafficking: the Nigerian case.
    Obot IS
    Soc Sci Med; 1992 Aug; 35(4):481-93. PubMed ID: 1519101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public opinion and drug policy in Australia: engaging the 'affected community'.
    Lancaster K; Ritter A; Stafford J
    Drug Alcohol Rev; 2013 Jan; 32(1):60-6. PubMed ID: 22897488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injecting nation: achieving control of hepatitis C in Australia.
    Wodak A
    Drug Alcohol Rev; 1997 Sep; 16(3):275-84. PubMed ID: 16203436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.